Conference on Financial Technology

Guests of Honour

 

Dr David Chung, JP, Under Secretary for Innovation and Technology

Dr Chung was Under Secretary for Innovation and Technology from March 2016 to June 2017.

Dr Chung has nearly 30 years of experience in information technology (IT) strategic management and entrepreneurship development, and worked in several IT firms. He joined Hong Kong Cyberport Management Company Limited in March 2004 and was responsible for taking forward Cyberport's IT infrastructure and incubation. He was Chief Technology Officer when he left Cyberport in February 2016. Public service positions held by Dr Chung include Council Member of the Hong Kong Computer Society, Convenor of the IT Expert Advisory Group of the Consumer Council, and Member of the Hong Kong/Guangdong Expert Committee on Cloud Computing Services and Standards.

[Top]

Professor Rocky S. TUAN, Vice Chancellor/President, The Chinese University of Hong Kong

Professor Rocky S. Tuan assumed office as the eighth Vice-Chancellor and President of The Chinese University of Hong Kong (CUHK) on 1 January 2018. Born and raised in Hong Kong, he pursued further studies in the United States and received his PhD in Life Sciences in 1977 from the Rockefeller University in New York. He is concurrently Lee Quo Wei and Lee Yick Hoi Lun Professor of Tissue Engineering and Regenerative Medicine at CUHK.

Professor Tuan is an internationally renowned biomedical scientist specializing in musculoskeletal biology and tissue regeneration, whose work covers both basic science and engineering, as well as translational and clinical applications. His research accomplishments are in the areas of cell and developmental biology, stem cells, biomaterials, tissue engineering, regenerative medicine, 3D printing, and tissue chip technologies. He directs a multidisciplinary research programme, focusing on the study of biological activities that are important for the development, growth, function, and health of musculoskeletal tissues, and the translation of this knowledge to develop technologies that will regenerate and/or restore functions to diseased and damaged tissues, particularly those related to trauma, injuries, and aging.

[Top]